Ahmad Aliyu
Overview
Explore the profile of Ahmad Aliyu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adelekan B, Harry-Erin B, Okposo M, Aliyu A, Ndembi N, Dakum P, et al.
PLoS One
. 2022 Feb;
17(2):e0263921.
PMID: 35157737
Introduction: While antiretroviral therapy (ART) coverage for pregnant women has undergone steady scale-up, Nigeria's final mother- to-child transmission of HIV (MTCT) rate remains unacceptably high at 10%. This study aimed...
2.
Adeoti A, Demir E, Adeyemi S, Yakutcan U, Kengne A, Kayode G, et al.
Pan Afr Med J
. 2021 Dec;
40:163.
PMID: 34970405
Introduction: sub-Saharan African countries contribute substantially to the global HIV disease burden. Despite this burden, and the promises that prevention could deliver, the implementation and uptake of HIV prevention programmes...
3.
Jahun I, Said I, El-Imam I, Ehoche A, Dalhatu I, Yakubu A, et al.
PLoS One
. 2021 Sep;
16(9):e0257476.
PMID: 34543306
Background: Ineffective linkage to care (LTC) is a known challenge for community HIV testing. To overcome this challenge, a robust linkage to care strategy was adopted by the 2018 Nigeria...
4.
Boyd A, Jahun I, Dirlikov E, Greby S, Odafe S, Abdulkadir A, et al.
AIDS Res Ther
. 2021 Sep;
18(1):62.
PMID: 34538268
Background: To accelerate progress toward the UNAIDS 90-90-90 targets, US Centers for Disease Control and Prevention Nigeria country office (CDC Nigeria) initiated an Antiretroviral Treatment (ART) Surge in 2019 to...
5.
Ndembi N, Murtala-Ibrahim F, Tola M, Jumare J, Aliyu A, Alabi P, et al.
AIDS Res Ther
. 2020 Nov;
17(1):64.
PMID: 33143751
Background: A substantial number of persons living with HIV (PLWH) in Nigeria do not experience durable viral suppression on first-line antiretroviral therapy (ART). Understanding risk factors for first-line treatment failure...
6.
El Bouzidi K, Kemp S, Datir R, Murtala-Ibrahim F, Aliyu A, Kwaghe V, et al.
J Antimicrob Chemother
. 2020 Feb;
75(6):1575-1579.
PMID: 32105319
Objectives: HIV-1 integrase inhibitors are recommended as first-line therapy by WHO, though efficacy and resistance data for non-B subtypes are limited. Two recent trials have identified the integrase L74I mutation...
7.
Predictors of loss to follow-up in art experienced patients in Nigeria: a 13 year review (2004-2017)
Aliyu A, Adelekan B, Andrew N, Ekong E, Dapiap S, Murtala-Ibrahim F, et al.
AIDS Res Ther
. 2019 Oct;
16(1):30.
PMID: 31594539
Background: Expanded access to antiretroviral therapy (ART) leads to improved HIV/AIDS treatment outcomes in Nigeria, however, increasing rates of loss to follow-up among those on ART is threatening optimal standard...
8.
Aliyu A, El-Kamary S, Brown J, Agins B, Ndembi N, Aliyu G, et al.
AIDS Res Ther
. 2019 Oct;
16(1):29.
PMID: 31575377
Background: As antiretroviral therapy (ART) programs expand access, there is an increase in burden to a healthcare system. These results are reduced provider-patient contact time and poor programmatic and patient...
9.
Adelekan B, Andrew N, Nta I, Gomwalk A, Ndembi N, Mensah C, et al.
AIDS Res Ther
. 2019 Aug;
16(1):17.
PMID: 31405386
Background: People living with HIV (PLHIV) constantly need to address social issues such as the cost of accessing care, stigma, and lack of social support which impacts on their level...
10.
Jumare J, El-Kamary S, Magder L, Hungerford L, Ndembi N, Aliyu A, et al.
J Neurovirol
. 2018 Sep;
24(6):712-719.
PMID: 30168015
Plasma HIV RNA level has been shown to correlate with HIV disease progression, morbidity, and mortality. We examined the association between levels of plasma HIV RNA and cognitive function among...